BACKGROUND: Asthma in obese adults is typically more severe and less responsive to glucocorticoids than asthma in nonobese adults. OBJECTIVE: We sought to determine whether the clearance of apoptotic inflammatory cells (efferocytosis) by airway macrophages was associated with altered inflammation and reduced glucocorticoid sensitivity in obese asthmatic patients. METHODS: We investigated the relationship of efferocytosis by airway (induced sputum) macrophages and blood monocytes to markers of monocyte programming, in vitro glucocorticoid response, and systemic oxidative stress in a cohort of adults with persistent asthma. RESULTS: Efferocytosis by airway macrophages was assessed in obese (n=14) and nonobese (n=19) asthmatic patients. Efferocytosis by macrophages was 40% lower in obese than nonobese subjects, with a mean efferocytic index of 1.77 (SD, 1.07) versus 3.00 (SD, 1.25; P<.01). A similar reduction of efferocytic function was observed in blood monocytes of obese participants. In these monocytes there was also a relative decrease in expression of markers of alternative (M2) programming associated with efferocytosis, including peroxisome proliferator-activated receptor δ and CX3 chemokine receptor 1. Macrophage efferocytic index was significantly correlated with dexamethasone-induced mitogen-activated protein kinase phosphatase 1 expression (ρ=0.46, P<.02) and baseline glucocorticoid receptor α expression (ρ=0.44, P<.02) in PBMCs. Plasma 4-hydroxynonenal levels were increased in obese asthmatic patients at 0.33 ng/mL (SD, 0.15 ng/mL) versus 0.16 ng/mL (SD, 0.08 ng/mL) in nonobese patients (P=.006) and was inversely correlated with macrophage efferocytic index (ρ=-0.67, P=.02). CONCLUSIONS: Asthma in obese adults is associated with impaired macrophage/monocyte efferocytosis. Impairment of this anti-inflammatory process is associated with altered monocyte/macrophage programming, reduced glucocorticoid responsiveness, and systemic oxidative stress.
BACKGROUND:Asthma in obese adults is typically more severe and less responsive to glucocorticoids than asthma in nonobese adults. OBJECTIVE: We sought to determine whether the clearance of apoptotic inflammatory cells (efferocytosis) by airway macrophages was associated with altered inflammation and reduced glucocorticoid sensitivity in obese asthmaticpatients. METHODS: We investigated the relationship of efferocytosis by airway (induced sputum) macrophages and blood monocytes to markers of monocyte programming, in vitro glucocorticoid response, and systemic oxidative stress in a cohort of adults with persistent asthma. RESULTS: Efferocytosis by airway macrophages was assessed in obese (n=14) and nonobese (n=19) asthmatic patients. Efferocytosis by macrophages was 40% lower in obese than nonobese subjects, with a mean efferocytic index of 1.77 (SD, 1.07) versus 3.00 (SD, 1.25; P<.01). A similar reduction of efferocytic function was observed in blood monocytes of obeseparticipants. In these monocytes there was also a relative decrease in expression of markers of alternative (M2) programming associated with efferocytosis, including peroxisome proliferator-activated receptor δ and CX3 chemokine receptor 1. Macrophage efferocytic index was significantly correlated with dexamethasone-induced mitogen-activated protein kinase phosphatase 1 expression (ρ=0.46, P<.02) and baseline glucocorticoid receptor α expression (ρ=0.44, P<.02) in PBMCs. Plasma 4-hydroxynonenal levels were increased in obese asthmaticpatients at 0.33 ng/mL (SD, 0.15 ng/mL) versus 0.16 ng/mL (SD, 0.08 ng/mL) in nonobese patients (P=.006) and was inversely correlated with macrophage efferocytic index (ρ=-0.67, P=.02). CONCLUSIONS:Asthma in obese adults is associated with impaired macrophage/monocyte efferocytosis. Impairment of this anti-inflammatory process is associated with altered monocyte/macrophage programming, reduced glucocorticoid responsiveness, and systemic oxidative stress.
Authors: Anne M Fitzpatrick; W Gerald Teague; Leandrea Burwell; Meredith S Brown; Lou Ann S Brown Journal: Pediatr Res Date: 2011-02 Impact factor: 3.756
Authors: Philip E Silkoff; Serpil C Erzurum; Jon O Lundberg; Steven C George; Nandor Marczin; John F Hunt; Richard Effros; Ildiko Horvath Journal: Proc Am Thorac Soc Date: 2006-04
Authors: S Courtney Frasch; Ruby F Fernandez-Boyanapalli; Karin Zemski Berry; Christina C Leslie; Joseph V Bonventre; Robert C Murphy; Peter M Henson; Donna L Bratton Journal: J Biol Chem Date: 2011-02-04 Impact factor: 5.157
Authors: Augusto A Litonjua; David Sparrow; Lucille Guevarra; George T O'Connor; Scott T Weiss; David J Tollerud Journal: Ann Allergy Asthma Immunol Date: 2003-04 Impact factor: 6.347
Authors: Kathleen McPhillips; William J Janssen; Moumita Ghosh; Aideen Byrne; Shyra Gardai; Linda Remigio; Donna L Bratton; Jihee L Kang; Peter Henson Journal: J Immunol Date: 2007-06-15 Impact factor: 5.422
Authors: Sarah J Heasman; Katherine M Giles; Adriano G Rossi; Judith E Allen; Christopher Haslett; Ian Dransfield Journal: Eur J Immunol Date: 2004-06 Impact factor: 5.532
Authors: Takeshi Tanaka; Jenna M Doe; Sarah A Horstmann; Shama Ahmad; Aftab Ahmad; Sung-Joon Min; Paul R Reynolds; Saritha Suram; Jeanette Gaydos; Ellen L Burnham; R William Vandivier Journal: J Biol Chem Date: 2014-02-25 Impact factor: 5.157
Authors: Jason E Lang; Anne M Fitzpatrick; David T Mauger; Theresa W Guilbert; Daniel J Jackson; Robert F Lemanske; Fernando D Martinez; Robert C Strunk; Robert S Zeiger; Wanda Phipatanakul; Leonard B Bacharier; Jacqueline A Pongracic; Fernando Holguin; Michael D Cabana; Ronina A Covar; Hengameh H Raissy; Monica Tang; Stanley J Szefler Journal: J Allergy Clin Immunol Date: 2017-12-19 Impact factor: 10.793
Authors: Meredith C McCormack; Andrew J Belli; Deepak A Kaji; Elizabeth C Matsui; Emily P Brigham; Roger D Peng; Cortlandt Sellers; D'Ann L Williams; Gregory B Diette; Patrick N Breysse; Nadia N Hansel Journal: Eur Respir J Date: 2015-01-08 Impact factor: 16.671
Authors: Kim D Lu; Krikor Manoukian; Shlomit Radom-Aizik; Dan M Cooper; Stanley P Galant Journal: Pediatr Exerc Sci Date: 2015-11-30 Impact factor: 2.333